Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 6Gastrointestinal 4Gynecologic 3Endocrine 3CNS 3Thoracic 2Sarcoma 2NET 2Head & Neck 2Other solid neoplasm 1Other hematologic neoplasm 1Dermatologic 1Breast 1

Conditions

Sarcoma 9Breast Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Sarcoma, Ewing 2Salivary Gland Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Gliosarcoma 2Glioblastoma 2Cholangiocarcinoma 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Solitary Fibrous Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Pheochromocytoma 1Penile Neoplasms 1Paraganglioma 1

Interventions

pembrolizumab 3poly ICLC 2fludarabine 2belinostat 2aflibercept 2Radiosurgery 2Fluorodeoxyglucose F18 2Filgrastim 2Docetaxel 2Cyclophosphamide 2Carboplatin 2vocimagene amiretrorepvec 1tremelimumab 1trastuzumab deruxtecan 1seribantumab 1rucaparib 1romidepsin 1resiquimod 1palbociclib 1etoposide phosphate 1entinostat 1durvalumab 1ciforadenant 1cemiplimab 1cc-486 1avelumab 1amminedichloro(2-methylpyridine)platinum(II) 1Trastuzumab 1Thalidomide 1Taxes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Fluorodeoxyglucose F18 × Sarcoma × Clear all
NCT06503146 2026-05-19

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
320 enrolled
CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT07118176 2025-08-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
30 enrolled
BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETSarcomaThoracic

Adrenal Gland Neoplasms, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary, Cholangiocarcinoma, Neuroendocrine Tumors, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡